Skip to main content
Equibles

Caption Management, LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,487,096
+$1,486,691 QoQ
Shares Held
227,733
+164923.9% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#30
of 111 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Derivatives in ACHV

reported options exposure · as of Jun 30, 2026
CallValue
$7,676,015
CallShares
1,175,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. ACHV ranks #33 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in ACHV

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,487,096 227,733
2026-06-30 $7,676,015 1,175,500
2026-03-31 $405 138
2026-03-31 $88,200 30,000
2025-12-31 $149,100 30,000
2025-12-31 $187,344 37,695
2025-09-30 $630,000 200,000
2025-06-30 $452,000 200,000
2024-09-30 $196,236 41,400
2024-06-30 $506,190 107,700